Literature DB >> 10385477

Benign ethnic neutropenia: what is a normal absolute neutrophil count?

T B Haddy1, S R Rana, O Castro.   

Abstract

Approximately 25% to 50% of persons of African descent and some ethnic groups in the Middle East have benign ethnic neutropenia, with low leukocyte and neutrophil counts. It is important to recognize the existence of this condition, the most common form of neutropenia throughout the world, and thus avoid both under-and overevaluation. Although there is no scientific basis for an absolute neutrophil count of 1.5x10(9)/L to be considered minimal, counts below this level are empirically regarded as inadequate in persons of all ethnic groups who are above the age of 1 year. Many individuals, however, maintain consistently low absolute neutrophil counts without evidence of increased susceptibility to infection or any other adverse effect. The important determination is not how many neutrophils are present in the peripheral blood, but whether the bone marrow is able to produce enough normally functioning cells when needed. A description of benign ethnic neutropenia, as set forth in this review, suggests that the lower limit now considered acceptable for the absolute neutrophil count should be readjusted downward for all ethnic groups.

Entities:  

Mesh:

Year:  1999        PMID: 10385477     DOI: 10.1053/lc.1999.v133.a94931

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  86 in total

Review 1.  Best practice in primary care pathology: review 7.

Authors:  W S A Smellie; J Forth; S R S Smart; M J Galloway; W Irving; D Bareford; P O Collinson; K G Kerr; G Summerfield; P J Carey; Rubin Minhas
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

Review 2.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

3.  Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?

Authors:  Matthew M Hsieh; John F Tisdale; Griffin P Rodgers; Neal S Young; Edward L Trimble; Richard F Little
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

4.  Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy.

Authors:  Babafemi Taiwo; Elizabeth L Yanik; Sonia Napravnik; Patrick Ryscavage; Susan L Koletar; Richard Moore; W Christopher Mathews; Heidi M Crane; Kenneth Mayer; Anne Zinski; James S Kahn; Joseph J Eron
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

5.  Incidence and potential causative factors associated with chronic benign neutropenia in the Kingdom of Saudi Arabia.

Authors:  Mamdooh Gari; Mohammed Dakhakhni; Abdullah Gari; Erada Alshihri; Rowan Al-Jahdali; Kothandaraman Narasimhan; Shen Liang; Fatin Al-Sayes; Gauthaman Kalamegam; Adeel Chaudhary; Adel Abuzenadah; Mohammed Al-Qahtani
Journal:  BMC Proc       Date:  2015-01-15

6.  Identification and Clinical Characterization of Children With Benign Ethnic Neutropenia.

Authors:  Michael V Ortiz; Emily R Meier; Matthew M Hsieh
Journal:  J Pediatr Hematol Oncol       Date:  2016-04       Impact factor: 1.289

7.  Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men.

Authors:  Catherine N Le; Paula Britto; Sean S Brummel; Risa M Hoffman; Jonathan Z Li; Patricia M Flynn; Taha E Taha; Anne Coletti; Mary Glenn Fowler; Ronald J Bosch; Rajesh T Gandhi; Karin L Klingman; James A McIntyre; Judith S Currier
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

Review 8.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

9.  The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.

Authors:  Hemant Kulkarni; Vincent C Marconi; Weijing He; Michael L Landrum; Jason F Okulicz; Judith Delmar; Dickran Kazandjian; John Castiblanco; Seema S Ahuja; Edwina J Wright; Robin A Weiss; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  Blood       Date:  2009-07-20       Impact factor: 22.113

10.  Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study.

Authors:  Steven C Hunt; Wei Chen; Jeffrey P Gardner; Masayuki Kimura; Sathanur R Srinivasan; John H Eckfeldt; Gerald S Berenson; Abraham Aviv
Journal:  Aging Cell       Date:  2008-05-02       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.